Letter questions study of preoperative GLP-1 agonists in abdominoplasty patients
Correspondence in Aesthetic Plastic Surgery responds to a prospective single-center study of thromboinflammatory markers in surgical patients on incretin drugs.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 14 20:00 ETSource: Aesthetic plastic surgery
The wire
- 01Nosratzehi and colleagues published a letter to the editor on a prospective monocentric study of preoperative GLP-1 receptor agonists and thromboinflammatory markers in abdominoplasty patients.
- 02Surgeons and prescribers are still working out perioperative management for patients on incretin drugs, and journal correspondence shapes how the underlying data get read.
- 03Only the letter's title is available here; the specific methodological objections and any author reply are not detailed.
From the source
Read at pubmed.ncbi.nlm.nih.govLetter to the Editor on "Preoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study"
Aesthetic plastic surgery · 2026 Oct 15 · Nosratzehi M, Nosratzehi S, Rostami M et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42881299/
